Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension	lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder	Not yet recruiting	Not applicable	2025-05-23		NCT06987097

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nanjing First Hospital, Nanjing Medical University	96

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials